Supporting 0 to 1 (Idea to NewCo)

Biotech Startups

Viva Ventures Biotech Fund

We are a corporate VC fund that focuses on investments in global first-in-class, discovery-stage biotech startups with significant growth potential. Viva Ventures is one of very few biotech VCs that have extensive expertise and industry know-how for early stage investments.

Supporting Biotech Startups since 2008

Viva Ventures Biotech Fund is backed by the founders of top biotech startups and chief scientists of incubator centers, giving us access to the top startups around the world including Viva Biotech incubators, Boston CIC, and Hong Kong Science Park. Viva Ventures Fund I is purely financed by Dr. Jun Mao.

Our Strategies

Our Investment Thesis:

Early Stage = Achieve Superior Return

How to Achieve Higher Success Rate:

Genetic Linkage, Biomarkers and SBDD

Phase 2a/2 Clinical Success Rates

Impact of Structure-Based Drug Design (SBDD)

*Source: Nature Review, Volume 13, June 2014

Projects that showed greater confidence in target validation through human genetic target linkage to the disease were less likely to fail owing to a lack of efficacy
73% of projects with some genetic linkage of the target to the disease were active or successful in Phase II compared with 43% of projects without such data, also that of projects with biomarkers could exceed 80%

Deal Flow Funnel

Global Ecosystem for Deal Sourcing and Exiting

Global Pharmas and Biotech Companies Include:

Our Portfolio Overview

Diversified Portfolio

* Including all the projects invested by Fund I, Fund II and Fund III

Our Team

Fund Management

Jun Mao, PhD (UK)

Founder and Chairwoman

Founding Director of Viva Biotech, a HK listed company with 100X+ investment return
Active biotech investor since 2008, invested 13 biotech and drug discovery startups
Working at top tier IB in City of London 1996-2009 after Ph.D. in Theoretical Physics (UK)

Lou Tartaglia, PhD (US)

Partner

Former Partner at Third Rock Ventures, CEO of Solstice Biologics, General Manager at GeneLogic, and Vice President of Metabolic Diseases at Millennium Pharmaceuticals

About 30 Top GP Advisory Partners

20+ years top biotech VC and/or drug discovery businesses

Our partners have extensive experience & track record:

GP Advisory Partners’ Role

Deal Sourcing
Deal Evaluation
DD & Negotiation
Exit Support

GP Advisory Partners’ Profile

Inventors of listed/ clinical stage drugs
20+ years of experience in drug discovery
Diversified expertise
Carry sharing
None compete
Right of first to know

Contact Us

Send us a business plan

If you have a great early-stage biotechnological or pharmaceutical project align with our investment strategy, please send your business plan to info@vivaventuresbiotech.com. We look forward to it!